Gene Transfer Technologies Market to Reach $5.93 Billion by 2029
The global Gene Transfer Technologies Market is projected to grow from USD 3.73 billion in 2024 to USD 5.93 billion by 2029, registering a CAGR of 9.7% during the forecast period. Market growth is fueled by increasing adoption of personalized medicine, expanding applications in gene therapy, and rising investments in biotechnology and advanced therapeutics
Download...
Drug Screening Market Poised for Strong Growth Amid Rising Polysubstance Use and Expanding Workplace Testing
The global Drug Screening Industry is undergoing a major transformation as governments, healthcare systems, employers, and law enforcement agencies intensify efforts to address rising substance abuse and workplace safety concerns. According to the latest analysis, the global drug screening market is projected to grow from USD 10.36 billion in 2025 to USD 21.29 billion by 2030, registering a robust...
Healthcare Quality Management Market to Reach $2.51 Billion by 2030
The global Healthcare Quality Management (QMS) Market is projected to grow from USD 1.42 billion in 2025 to USD 2.51 billion by 2030, at a CAGR of 12.1% during the forecast period. Growth is fueled by increasing regulatory requirements, expanding use of interoperable health data, and the need for improved patient safety and operational efficiency across healthcare systems.
Download...
Orthopedic Biomaterials: Transforming the Future of Bone and Joint Repair
Orthopedic Biomaterials have become a cornerstone of modern musculoskeletal healthcare, enabling surgeons to restore mobility, repair damaged tissues, and improve the quality of life for millions of patients worldwide. From joint replacement implants to advanced bioresorbable fixation systems, these materials are revolutionizing orthopedic treatments through enhanced durability, biocompatibility,...
Single-Use Bioprocessing Market to Reach $33.67 Billion by 2030 | Growth, Trends & Opportunities
The global single-use bioprocessing market is projected to grow from USD 18.01 billion in 2025 to USD 33.67 billion by 2030, registering a CAGR of 13.3% during the forecast period. This rapid expansion is driven by the increasing adoption of single-use technologies among CDMOs and CMOs, rising demand for cost-efficient production, reduced risk of cross-contamination, and lower capital investment requirements.
Market...
Mice Model Market to Reach $2.74 Billion by 2030
The global Mice Model Market is projected to grow from USD 1.70 billion in 2025 to USD 2.74 billion by 2030, registering a CAGR of 10.0% during the forecast period. Growth is being fueled by increasing reliance on mice models in preclinical research, rising adoption of mouse clinical trials (MCTs), and expanding applications in personalized medicine—particularly in oncology.
Download...
Nuclear Medicine Software Market: Powering the Next Generation of Precision Healthcare
The global healthcare industry is undergoing a major digital transformation, and nuclear medicine is at the center of this evolution. As hospitals and diagnostic centers increasingly adopt advanced imaging technologies and personalized treatment approaches, the demand for sophisticated nuclear medicine software solutions is accelerating rapidly.
According to recent market estimates, the global...
Nuclear Medicine Equipment Market Growth 2030: Theranostics, AI Imaging & Precision Medicine Driving the Future
The global nuclear medicine equipment market is on a steady growth trajectory, projected to reach USD 8.31 billion by 2030, up from USD 6.63 billion in 2025, expanding at a CAGR of 4.6% during the forecast period. This growth is largely fueled by the increasing burden of chronic diseases such as cancer and cardiovascular disorders, alongside the rising demand for early, accurate, and non-invasive...
Companion Diagnostics Market Poised for Robust Growth Through 2029
The global Companion Diagnostics Market is experiencing rapid expansion as precision medicine continues to reshape modern healthcare. According to industry projections, the market is expected to grow from USD 7.5 billion in 2024 to USD 13.6 billion by 2029, registering a CAGR of 12.6% during the forecast period. Companion diagnostics (CDx) have become an essential component in personalized medicine,...